Methadone for cancer pain (Q24243228)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Methadone for cancer pain (English)

0 references

1 reference

Alexander B Nicholson

series ordinal

1

0 references

publication date

17 October 2007

0 references

published in

0 references

cites work

A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

DOUBLE BLIND TRIAL OF DEXTROMORAMIDE, METHADONE AND PETHIDINE IN THE TREATMENT OF SEVERE PAIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

A randomized study on oral administration of morphine and methadone in the treatment of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Management of chronic neuropathic pain with methadone: a review of 13 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone: outpatient titration and monitoring strategies in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Patient-controlled analgesia with oral methadone in cancer pain: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Treatment of pain in chronic bowel subobstruction with self-administration of methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone response in advanced cancer patients with pain followed at home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Rapid switching from morphine to methadone in cancer patients with poor response to morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Rapid switching between transdermal fentanyl and methadone in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone titration in opioid-resistant cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone is safe for treating hospitalized patients with severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone use in cancer patients with pain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone in the management of cancer pain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

An update on the clinical use of methadone for cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

Methadone in pain uncontrolled by morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Local toxicity with subcutaneous methadone. Experience of two centers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

A prospective multicenter assessment of the Edmonton staging system for cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Combination therapy with ibuprofen and methadone for chronic cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Subcutaneous methadone in terminally ill patients: manageable local toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Clinical evaluation of oral methadone in treatment of cancer pain.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Successful use of methadone in nociceptive cancer pain unresponsive to morphine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021

Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003971.PUB3

7 January 2021